#South Korea #Seoul #Sky Labs #CART BP #OMRON Ventures

Sky Labs and OMRON Ventures: A Strategic Partnership

On November 4, 2025, Sky Labs made headlines with the announcement that it has secured investments from OMRON Ventures, a subsidiary of the Omron Group based in Minato-ku, Tokyo. This partnership transcends mere financial backing; it represents a strategic alliance aimed at enhancing Sky Labs' global business expansion, particularly in the healthcare sector.

Partnership Details and Intent

In addition to the investment, Sky Labs has signed a Memorandum of Understanding (MoU) with OMRON Healthcare Co., Ltd., a renowned leader in blood pressure monitoring devices. This agreement reinforces their commitment to collaborating on various fronts, significantly strengthening their partnership.

The collaboration stems from the success of Sky Labs’ innovative product, the “CART BP,” a state-of-the-art ring-based blood pressure monitoring device. This device is not only groundbreaking due to its continuous monitoring capabilities but is also pivotal in addressing chronic disease prevention and management on a global scale.

The CART BP Device

The CART BP device stands out as the world’s first cuffless, ring-shaped blood pressure monitor. An exceptional feature is its ability to measure blood pressure continuously throughout the day, during sleep, and in various situations, thus helping to mitigate risks associated with hypertension and cardiovascular diseases. Users can seamlessly track changes and trends in their blood pressure via a user-friendly interface without the need to visit a medical facility.

OMRON Healthcare, a trailblazer in medical technology, supplies blood pressure monitoring solutions across more than 130 countries. To date, their global sales have surpassed 400 million devices, a testament to their dedication to improving home monitoring and healthcare solutions.

A Vision for Growth

Jack Byunghwan Lee, CEO of Sky Labs, commented on the partnership, expressing enthusiasm for the collaborative efforts to elevate healthcare technology globally. He stated, “Our strategic partnership is a significant victory, validating the clinical effectiveness and economic feasibility of Sky Labs’ technology on an international level. Together with OMRON Healthcare, we aim to pave the way for significant innovations in chronic disease management.”

Sky Labs, established in September 2015, focuses on developing wearable health technology that leverages cardiac signals tracked through optical sensors. The company has made significant strides in developing innovative medical devices that enhance patient quality of life.

Future Endeavors

As part of this strategic agenda, Sky Labs is preparing for the domestic launch of the CART BP device, having signed an exclusive distribution agreement with Daewoong Pharmaceutical. This initiative aims to make the device accessible to hospitals, clinics, and general consumers, ensuring that advanced health monitoring technology reaches those who need it most.

In conclusion, the partnership between Sky Labs and OMRON Ventures signifies not only a financial investment but a shared vision for healthcare innovation that prioritizes preventive measures and chronic disease management. As they forge ahead, the implications of this collaboration could be transformative, setting new standards in health technology advancement and accessibility.